•
Dec 31, 2016

ResMed Q2 2017 Earnings Report

Total Revenue
$530M
Previous year: $455M
+16.7%
EPS
$0.73
Previous year: $0.69
+5.8%
Gross Profit
$309M
Previous year: $267M
+16.0%
Cash and Equivalents
$788M
Previous year: $659M
+19.6%
Free Cash Flow
$191M
Total Assets
$3.32B
Previous year: $2.24B
+48.4%

ResMed

ResMed